Terry Lundgren - Vicarious Surgical Independent Director
| RBOT Stock | USD 5.46 0.03 0.55% |
Insider
Terry Lundgren is Independent Director of Vicarious Surgical since 2020.
| Age | 67 |
| Tenure | 5 years |
| Phone | 617 868 1700 |
| Web | https://www.vicarioussurgical.com |
Vicarious Surgical Management Efficiency
The company has return on total asset (ROA) of (0.5773) % which means that it has lost $0.5773 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2563) %, meaning that it created substantial loss on money invested by shareholders. Vicarious Surgical's management efficiency ratios could be used to measure how well Vicarious Surgical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Raja Bal | indie Semiconductor | N/A | |
| Douglas Doerfler | MaxCyte | 69 | |
| BA Chemistry | Orthofix Medical | 63 | |
| Todd Rearick | QuantumSi | N/A | |
| Alaleh Nouri | Procept Biorobotics Corp | 46 | |
| Stark Thompson | MaxCyte | 83 | |
| Lou DeSorbo | Rigetti Computing | N/A | |
| Michael McKenna | QuantumSi | 62 | |
| Ehab Esmail | Orthofix Medical | 53 | |
| Brian Sereda | Rigetti Computing | 63 | |
| Ellen Bancroft | indie Semiconductor | 58 | |
| Yang MD | Humacyte | 59 | |
| Cenk Sumen | MaxCyte | 50 | |
| Thomas Yorkey | Procept Biorobotics Corp | 62 | |
| Michael Harburn | Rigetti Computing | 54 | |
| Sri Radhakrishnan | Pulmonx Corp | N/A | |
| Heather Prichard | Humacyte | 47 | |
| Patrick Schneider | QuantumSi | N/A | |
| Dale Sander | Humacyte | 65 | |
| Claudia Drayton | QuantumSi | 56 | |
| Jonathan Rothberg | QuantumSi | 61 | |
Management Performance
| Return On Equity | -1.26 | ||||
| Return On Asset | -0.58 |
Vicarious Surgical Leadership Team
Elected by the shareholders, the Vicarious Surgical's board of directors comprises two types of representatives: Vicarious Surgical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Vicarious. The board's role is to monitor Vicarious Surgical's management team and ensure that shareholders' interests are well served. Vicarious Surgical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Vicarious Surgical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| CPA CPA, CFO Treasurer | ||
| June Esq, Gen Officer | ||
| Terry Lundgren, Independent Director | ||
| Sammy Khalifa, CTO Cofounder | ||
| John Mazzola, VP Operations | ||
| Sarah CPA, Chief Officer | ||
| Stephen From, CEO Director | ||
| Michael Kives, Independent Director | ||
| David Ho, Independent Director | ||
| William CPA, CFO Treasurer | ||
| Randolph Clark, President | ||
| Donald Tang, President Director | ||
| Emma Plouffe, Senior People | ||
| Kaitlyn Brosco, Director Relations | ||
| Erin Checka, Head Secretary | ||
| David Chu, Chief Executive Officer, Director | ||
| Fred Langhammer, Independent Director | ||
| MD FACS, Cofounder Officer | ||
| Adam Sachs, President CoFounder | ||
| Robert Kirby, Chief Financial Officer |
Vicarious Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Vicarious Surgical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.26 | ||||
| Return On Asset | -0.58 | ||||
| Current Valuation | 21.73 M | ||||
| Shares Outstanding | 5.3 M | ||||
| Shares Owned By Insiders | 22.62 % | ||||
| Shares Owned By Institutions | 33.75 % | ||||
| Number Of Shares Shorted | 136.57 K | ||||
| Price To Earning | 8.61 X | ||||
| Price To Book | 1.41 X | ||||
| EBITDA | (61.12 M) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Vicarious Stock Analysis
When running Vicarious Surgical's price analysis, check to measure Vicarious Surgical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vicarious Surgical is operating at the current time. Most of Vicarious Surgical's value examination focuses on studying past and present price action to predict the probability of Vicarious Surgical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vicarious Surgical's price. Additionally, you may evaluate how the addition of Vicarious Surgical to your portfolios can decrease your overall portfolio volatility.